Two novel cadmium(II) complexes with demethylcantharate and polypyridyl: Crystal structure, interactions with DNA and bovine serum albumin

X-ray Structure Analyses and Biological Evaluations of a New Cd(II) Complex with S-Triazine Based Ligand

The crystal structure of a new penta-coordinated Cd(II) complex of the formula [Cd(BPMT)Br2] was presented. This Cd(II) complex was synthesized by mixing Cd(NO3)2·4H2O and 2,4-bis(3,5-dimethyl-1H-pyrazol-1-yl)-6-methoxy-1,3,5-triazine (BPMT) in the presence of KBr. It crystallized in the monoclinic crystal system and P21/n space group. The crystal parameters are a = 11.3680(8) Å, b = 11.1648(8) Å, c = 15.8593(11) Å, and β = 103.563(2)°, while the unit cell volume is 2190.6(12) Å3 and it comprised four molecules. The supramolecular structure of the [Cd(BPMT)Br2] complex is mainly controlled by the intermolecular Br∙∙∙H interactions. Hirshfeld calculations predicted the H∙∙∙H (38.1%), Br∙∙∙H (24.3%), C∙∙∙H (11.1%), and N∙∙∙H (9.5%) interactions are the most dominant. Biological evaluations for the antimicrobial and anticancer properties of the studied complex are presented. The Cd(II) complex has better anticancer and antibacterial activities than the free BPMT ligand. The anticancer activity against lung carcinoma (A-549) is higher for the former (18.64 ± 1.09 µg/mL) compared to the latter (372.79 ± 13.64 µg/mL). Additionally, the best antibacterial activity for the Cd(II) complex was found against B. subtilis.

A polythreaded MnII-MOF and its super-performances for dye adsorption and supercapacitors

One new polythreaded Mn^II-MOF was successfully prepared by employing a tridentate N-donor ligand with three long arms. Its excellent performances in dye adsorption and supercapacitor have been investigated in detail.

A novel binuclear hydrazone-based Cd(II) complex is a strong pro-apoptotic inducer with significant activity against 2D and 3D pancreatic cancer stem cells

A novel binuclear Cd complex (1) with hydrazone-based ligand was prepared and characterized by spectroscopy and single crystal X-ray diffraction techniques. Complex 1 reveals a strong pro-apoptotic activity in both human, mammary adenocarcinoma cells (MCF-7) and pancreatic AsPC-1 cancer stem cells (CSCs). While apoptosis undergoes mostly caspase-independent, 1 stimulates the activation of intrinsic pathway with noteworthy down regulation of caspase-8 activity in respect to non-treated controls. Distribution of cells over mitotic division indicates that 1 caused DNA damage in both cell lines, which is confirmed in DNA interaction studies. Compared to 1, cisplatin (CDDP) does not achieve cell death in 2D cultured AsPC-1 cells, while induces different pattern of cell cycle changes and caspase activation in 2D cultured MCF-7 cells, implying that these two compounds do not share similar mechanism of action. Additionally, 1 acts as a powerful inducer of mitochondrial superoxide production with dissipated trans-membrane potential in the majority of the treated cells already after 6 h of incubation. On 3D tumors, 1 displays a superior activity against CSC model, and at 100 μM induces disintegration of spheroids within 2 days of incubation. Fluorescence spectroscopy, along with molecular docking show that compound 1 binds to the minor groove of DNA. Compound 1 binds to the human serum albumin (HSA) showing that the HSA can effectively transport and store 1 in the human body. Thus, our current study strongly supports further investigations on antitumor activity of 1 as a drug candidate for the treatment of highly resistant pancreatic cancer.